13F filer · CIK 895421 ↗
Morgan Stanley
You are looking at Q3 2024. See the latest, Q2 2026 →
Reported value
$1.38T
+6.7% on the quarter before
Positions
7,927
451 new · 369 sold out
Top 10
20.4%
of the value
Est. gain
+$75.34B
on stocks held all quarter
Est. return
+6.0%
on those stocks since Q2 2024
Positions as of Sep 30, 2024, from Morgan Stanley's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.
Largest buys
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Tr~$1.80BAdded · 0.9% → 1.0%+3,128,222 shares
- Alphabet~$1.14BAdded · 1.6% → 1.5%+6,897,518 shares
- Vanguard Index Fds~$1.12BAdded · 0.8% → 0.8%+2,122,737 shares
- Cme Group Inc~$1.06BAdded · 0.1% → 0.2%+4,792,463 shares
- Booking Holdings Inc~$1.05BAdded · 0.1% → 0.2%+250,374 shares
- Meta~$928.6MAdded · 1.4% → 1.5%+1,622,152 shares
- Vanguard Bd Index Fds~$812.2MAdded · 0.5% → 0.5%+10,812,992 shares
- Autozone Inc~$752.2MAdded · 0.1% → 0.1%+238,791 shares
- Eli Lilly~$739.0MAdded · 1.0% → 0.9%+834,139 shares
- Berkshire Hathaway Inc Del~$722.0MAdded · 0.8% → 0.9%+1,568,680 shares
Largest sells
Since Q2 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$1.11BCut · 2.5% → 2.2%−5,974,728 shares
- Adobe~$1.08BCut · 0.4% → 0.3%−2,082,015 shares
- ServiceNow~$1.01BCut · 0.4% → 0.4%−1,131,752 shares
- Intercontinental Exchange In~$993.5MCut · 0.3% → 0.2%−6,184,877 shares
- Nvidia~$879.3MCut · 3.2% → 2.9%−7,240,991 shares
- Accenture Plc Ireland~$853.8MCut · 0.4% → 0.3%−2,415,445 shares
- Moody's Corporation~$703.5MCut · 0.1% → 0.1%−1,482,298 shares
- The Cigna Group~$638.9MCut · 0.2% → 0.1%−1,844,164 shares
- Ishares Tr~$614.4MCut · 0.1% → 0.1%−6,261,589 shares
- Thermo Fisher Scientific Inc~$591.3MCut · 0.5% → 0.5%−955,965 shares
Holdings
As of Sep 30, 2024. Changes are in shares against Jun 30, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +0.2% · price +10.6% | 3.9% | $53.93B | +$5.17B | ||||||||
| MicrosoftCOM · shares +1.0% · price −3.7% | 3.9% | $53.38B | −$2.04B | ||||||||
| NvidiaCOM · shares −2.1% · price −1.7% | 2.9% | $40.04B | −$692.4M | ||||||||
| AmazonCOM · shares −3.6% · price −3.6% | 2.2% | $29.73B | −$1.10B | ||||||||
| MetaCL A · shares +4.6% · price +13.5% | 1.5% | $21.09B | +$2.40B | ||||||||
| SPDR S&P 500 ETF TrTR UNIT · shares +1.9% · price +5.4% | 1.5% | $20.44B | +$1.03B | ||||||||
| AlphabetCAP STK CL A · shares +5.9% · price −8.9% | 1.5% | $20.42B | −$1.89B | ||||||||
| Jpmorgan Chase & Co.COM · shares +1.5% · price +4.3% | 1.1% | $14.60B | +$586.6M | ||||||||
| Ishares TrCORE S&P500 ETF · shares +14% · price +5.4% | 1.0% | $14.38B | +$645.2M | ||||||||
| Visa Inc.COM CL A · shares −0.9% · price +4.8% | 1.0% | $13.81B | +$626.7M | ||||||||
| Eli LillyCOM · shares +6.1% · price −2.1% | 0.94% | $12.90B | −$266.8M | ||||||||
| AlphabetCAP STK CL C · shares +1.3% · price −8.8% | 0.90% | $12.44B | −$1.19B | ||||||||
| BroadcomCOM · shares −0.8% · price +7.4% | 0.89% | $12.28B | +$850.6M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +6.3% · price +13.1% | 0.89% | $12.22B | +$1.34B | ||||||||
| Unitedhealth Group IncCOM · shares −0.3% · price +14.8% | 0.85% | $11.69B | +$1.51B | ||||||||
| Vanguard Index FdsS&P 500 ETF SHS · shares +11% · price +5.5% | 0.84% | $11.62B | +$548.1M | ||||||||
| TeslaCOM · shares −0.6% · price +32.2% | 0.76% | $10.48B | +$2.55B | ||||||||
| Ishares TrRUS 1000 GRW ETF · shares −0.2% · price +3.0% | 0.71% | $9.76B | +$282.6M | ||||||||
| Invesco Qqq TrUNIT SER 1 · shares +2.2% · price +1.9% | 0.63% | $8.75B | +$157.2M | ||||||||
| Home Depot IncCOM · shares +6.8% · price +17.7% | 0.63% | $8.75B | +$1.23B | ||||||||
| Procter And Gamble CoCOM · shares +1.7% · price +5.0% | 0.62% | $8.49B | +$399.4M | ||||||||
| Costco Whsl Corp NewCOM · shares +0.09% · price +4.3% | 0.61% | $8.38B | +$344.8M | ||||||||
| Exxon Mobil CorpCOM · shares +4.9% · price +1.8% | 0.59% | $8.13B | +$138.8M | ||||||||
| MastercardCL A · shares +1.8% · price +11.9% | 0.59% | $8.08B | +$845.7M | ||||||||
| Ishares TrCORE MSCI EAFE · shares +1.6% · price +7.4% | 0.57% | $7.83B | +$534.1M | ||||||||
| Total · 7,927 positions | 100% | $1.38T | +$75.34B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2024 to Q3 2024: 7,304 stocks held throughout, up $75.34B (+6.0%).
- Apple+$5.17B+11%
- Tesla+$2.55B+32%
- Meta+$2.40B+14%
- Unitedhealth Group Inc+$1.51B+15%
- Berkshire Hathaway Inc Del+$1.34B+13%
- Nvidia−$692.4M−2%
- Amazon−$1.10B−4%
- Alphabet−$1.19B−9%
- Alphabet−$1.89B−9%
- Microsoft−$2.04B−4%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 39 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $1.89T+14% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.66T−1% | SEC ↗ |
| Q4 2025 | May 27, 2026 (amended) | $1.67T+1% | SEC ↗ |
| Q3 2025 | May 27, 2026 (amended) | $1.65T+8% | SEC ↗ |
| Q2 2025 | Aug 15, 2025 | $1.54T+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $1.40T−2% | SEC ↗ |
| Q4 2024 | May 15, 2025 (amended) | $1.43T+3% | SEC ↗ |
| Q3 2024 | May 14, 2025 (amended) | $1.38T+7% | SEC ↗ |
| Q2 2024 | May 14, 2025 (amended) | $1.29T−65% | SEC ↗ |
| Q1 2024 | May 15, 2024 (amended) | $3.74T+65% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 (amended) | $2.27T+131% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $983.41B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.01T+9% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $932.64B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $880.47B+20% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $733.72B−5% | SEC ↗ |
| Q2 2022 | Oct 27, 2022 (amended) | $770.42B+4% | SEC ↗ |
| Q1 2022 | Oct 27, 2022 (amended) | $741.46B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $809.87B+9% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $742.48B−2% | SEC ↗ |
| Q2 2021 | Aug 23, 2021 (amended) | $758.13B+11% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $680.76B+5% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $647.47B+25% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $517.01B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $451.78B+23% | SEC ↗ |
| Q1 2020 | May 26, 2020 (amended) | $367.99B−14% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $430.00B+14% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $377.76B+1% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $375.74B+6% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $353.27B+6% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $334.17B−16% | SEC ↗ |
| Q3 2018 | Apr 23, 2019 (amended) | $399.53B+8% | SEC ↗ |
| Q2 2018 | Apr 23, 2019 (amended) | $370.13B+3% | SEC ↗ |
| Q1 2018 | Apr 23, 2019 (amended) | $360.30B−1% | SEC ↗ |
| Q4 2017 | Apr 23, 2019 (amended) | $365.35B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $333.86B+1% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $331.01B−49% | SEC ↗ |
| Q1 2017 | May 12, 2017 (amended) | $651.13B+7% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 (amended) | $611.12B+109% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $292.79B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $276.85B+7% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $259.85B | SEC ↗ |